ASCO 2023: Solid Tumors : vimarsana.com

Coverage of clinical trial results presented across a range of solid tumor cancers, including breast, ovarian, colorectal, and non-small cell lung cancer, among other types; as well as important findings in genomic testing.

Related Keywords

United States , Japan , Australia , University Of Chicago , Illinois , Germany , New Haven , Connecticut , China , Peking , Beijing , California , Singapore , National Taiwan University , T Ai Pei , Taiwan , Tennessee , Corrs , Texas , Long Wu , Hubei , Guangdong , Jilin , San Antonio , South Korea , Chicago , Chinese , American , Alpha Biopharma , Jie Wang , Dennisj Slamon , Debra Patt , Dennis Slamon , Borisa Hadaschik , Roys Herbst , Rita Nanda , Bradley Alexander Mcgregor , Nathan Pennell , Qing Zhou , Andrew Hertler , Mengzhao Wang , Daiichi Sankyo , Awny Farajallah , Jonathanw Riess , Tus Fruquintinib , Eli Lilly , James Yang , American Society Of Clinical Oncology Annual Meeting , Novartis , Century Health , University Of Duisburg , Solutions In Treating , Department Of Medicine , Dana Farber Cancer Institute , Department Of Urology , University Medical College , National Institutes Of Health , Caffreym New Century Health Andrew Hertler , Us Preventive Services Task , Department Of Investigational Cancer Therapeutics , Institute Of Oncology , E Committee Members , National Comprehensive Cancer Network , Sciences Corp , Devices Agency , National Taiwan University Cancer Center , European Society Of Medical Oncology , Essen University Hospital , National Cancer Institute , International Society Of Urologic Pathologists , Takeda Pharmaceuticals , Ovarian Cancer Research Alliance , San Antonio Breast Cancer Congress , University Of California , Yale School Of Medicine , American Society Of Clinical Oncology , Guangdong Lung Cancer Institute , Division Of Hematology Oncology , Vanderbilt University Medical Center , Cancer Center , Chinese Academy Of Medical Science , American Society Of Clinical Oncology Cancer , American Cancer Society , Yale Cancer Center , Lung Cancer Medical Oncology Program , University Of Texas Md Anderson Cancer Center , Astrazeneca , University Of Texas At Austin , European Medicines Agency , Expressing Cancers Across Multiple Tumor , American Society , Clinical Oncology , Annual Meeting , Funda Meric Bernstam , Investigational Cancer Therapeutics , Evidence Based Oncology , New Century Health , Patients Whose Cancers Were Detected With , Are Cancer Free , Exact Sciences , Durvalumab Improved , Patients Newly Diagnosed With Advanced Ovarian , Updated May , Cancer Research , Accessed June , Most Common Type , National Institutes , New England Journal , What Sets , Older Patients With , Early Breast Cancer , Dosing Management , Gynecologic Cancer Research Program , Sarah Cannon Research Institute , Antonio Breast Cancer Congress , More Comorbidities Among Older , Texas Oncology , Abemaciclib Combined With Endocrine Therapy , Adjuvant Treatment , Patients With Resected , Yale School , Cleveland Clinic Taussig Cancer , New Solutions , Clinical Oncology Annual , Comprehensive Cancer Center , Graduate Institute , Peking University Medical College , Chinese Academy , Medical Science , Breakthrough Therapy , American Cancer , Revised January , Hold Prognostic Utility , Clinical Oncology Annual Meeting , International Society , Urologic Pathologists , Priority Review , Confirm Safety , European Society , Medical Oncology , Medical Devices Agency , Prescription Drug User Fee , Services Task Force , New Drug Application , University Medical ,